Top of page

CAR-T Cell Therapy Support Meeting

This support meeting is open to people who are having, have had, or expect to have CAR-T cell therapy for their relapsed or refractory lymphoma. Meetings are on the fourth Tuesday of the month, at 11am.

Register for these meetings here

At these support meetings, you’ll meet others who are managing the challenges of this intensive treatment for relapsed or refractory lymphoma. CAR-T cell therapy usually involves a hospital stay and can have serious side effects, with a long recovery time. Although CAR-T cell therapy has developed considerably, there are still significant risks and the long-term effects are unknown. This brings added uncertainty for people who are already coping with the physical, emotional and practical effects of relapsed or refractory lymphoma.  

The types of lymphoma currently treated with CAR-T cell therapy are diffuse large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lymphoma (PMBL) and mantle cell lymphoma, though there are clinical trials being undertaken for other types, which you can explore on Lymphoma TrialsLink.   

Our support meetings provide a safe, confidential place where people affected by lymphoma can talk to each other about their experience, express their thoughts and feelings, gain insight from connecting with others, and get support and information. They last an hour and follow a common structure. The facilitator will listen, seek to understand your experience and help address any questions or worries you have. 

Support meetings are hosted on Zoom, but you don't need a Zoom account or experience of using Zoom. You will need access to an internet-enabled device with functioning microphone, speakers and camera

To register for the support meeting service, you must be aged 18 or over, resident in the UK, and personally affected by lymphoma. For more information, please see our full Online Support Meetings Terms of Use.